Development of cutaneous sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha 2b

J Cutan Med Surg. 2001 Sep-Oct;5(5):406-8. doi: 10.1177/120347540100500507.

Abstract

Background: Sarcoidosis is a multisystemic granulomatous disorder of unknown etiology that most commonly affects young adults. A probable induction of sarcoidosis by interferons (IFN) has been published. To this date, few cases of cutaneous sarcoidosis inpatients with chronic hepatitis C under interferon treatment have been reported.

Objective: We describe a 50-year-old woman with chronic hepatitis C who developed lesions of cutaneous sarcoidosis three months after IFN treatment.

Conclusions: The possible role of INF therapy in the development of cutaneous sarcoidosis in a patient with chronic hepatitis C should be considered.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • Female
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Middle Aged
  • Sarcoidosis / chemically induced*
  • Sarcoidosis / complications
  • Skin Diseases / chemically induced*
  • Skin Diseases / complications

Substances

  • Antiviral Agents
  • Interferon-alpha